Search results
Results from the WOW.Com Content Network
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...
Company/Organization Sector Local Full-time Employment Ohio State University* Education: 29,685 The State of Ohio* Government: 22,030 JPMorgan Chase: Financial Activities: 16,975 OhioHealth* Health Care: 16,000 Nationwide* Financial Activities: 11,235 United States Government: Government: 10,800 City of Columbus* Government: 8,653 Columbus ...
By Mariam Sunny and Kamal Choudhury (Reuters) -The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it the company's first wholly ...
IONIS School of Technology and Management; Ionis Pharmaceuticals This page was last edited on 30 September 2018, at 19:02 (UTC). Text is available under the ...
Ionis CEO Brett Monia said the company estimates that only 20% of the patients suffering from ATTR-PN are on treatment. "This is a market where more than one player can have great success," he added.
AOL Mail welcomes Verizon customers to our safe and delightful email experience!
The following is a list of stations that are affiliated with Ion Plus, a television network in the United States owned by Ion Media Networks.The network was originally in operation from 2007 to 2021 with a total of 65 affiliates, the vast majority of which were owned by its corporate parent.
The company is a spin-off from the Max Planck Institute for Biophysical Chemistry. [6] In 2002, Alnylam was founded by scientists Phillip Sharp, Paul Schimmel, David Bartel, Thomas Tuschl, and Phillip Zamore, and by investors Christoph Westphal and John Kennedy Clarke; John Maraganore was the founding CEO.